CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 72 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,202,000 | +56.5% | 113,059 | +68.7% | 1.82% | +93.3% |
| Q4 2019 | $7,799,000 | +108.6% | 67,019 | +105.2% | 0.94% | +145.8% |
| Q3 2019 | $3,738,000 | -21.7% | 32,657 | -37.6% | 0.38% | -10.5% |
| Q1 2019 | $4,776,000 | -26.4% | 52,349 | -38.7% | 0.43% | -69.0% |
| Q4 2018 | $6,485,000 | +459.1% | 85,436 | +489.2% | 1.38% | +727.5% |
| Q3 2018 | $1,160,000 | +233.3% | 14,500 | +314.3% | 0.17% | +247.9% |
| Q2 2018 | $348,000 | – | 3,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 131,657 | $13,077,000 | 5.92% |
| Point72 Hong Kong Ltd | 103,797 | $10,310,000 | 3.49% |
| York Capital Management Global Advisors, LLC | 827,738 | $82,219,000 | 2.00% |
| Parametrica Management Ltd | 3,889 | $386,000 | 1.83% |
| Athos Capital Ltd | 35,266 | $3,503,000 | 1.19% |
| Hillhouse Capital Management | 618,391 | $61,425,000 | 1.05% |
| JUPITER ASSET MANAGEMENT LTD | 502,812 | $49,940,000 | 0.73% |
| Black Creek Investment Management Inc. | 240,232 | $23,862,000 | 0.73% |
| COMGEST GLOBAL INVESTORS S.A.S. | 243,652 | $24,202,000 | 0.54% |
| Temasek Holdings (Private) Ltd | 990,000 | $98,337,000 | 0.52% |